Trump Media (DJT) Valuation: Is a 2x Price-to-Book Ratio Reasonable After the Rally?
December 20, 2025, 3:40 AM EST. Trump Media & Technology Group (DJT) has sprinted higher, with about an 8% intraday gain and a 50% rally over the past week; 30-day returns top 56%, yet the year-to-date still trails. On a price-to-book (P/B) of 2x, DJT looks modest relative to its peers, though not a bargain within the US Interactive Media and Services group. The market seems to assign a premium for its brand and platform potential, even as significant operating losses and unclear long-term user growth temper the story. A 2x P/B implies a cautious turnaround view – potentially mispriced if earnings materialize, but risky if engagement or monetization stalls. Readers can test scenarios using the analysis and the stock screener.
Top Stock Picks for 2026: Nvidia, AMD, and Broadcom Lead the AI-Driven Rally
December 20, 2025, 3:28 AM EST. As 2026 nears, investors are compiling a shopping list of AI-forward names. The author highlights Nvidia (NVDA) for leading the AI buildout and vast data-center capex, with 2030 forecasts suggesting trillions in spend. AMD (AMD) could narrow the GPU gap as it targets a 60% CAGR in data-center revenue over five years, up from a 22% pace in Q3. Broadcom (AVGO) is pursuing AI accelerators via hyperscaler partnerships, offering optimized ASICs that trade flexibility for cost efficiency, while its AI semiconductor revenue accelerates. The list also nods to Taiwan Semiconductor Manufacturing (TSMC) for its critical role in supply. Overall, 2026 looks set to reward AI-centric chipmakers and infrastructure names.
Wilmar International (SGX:F34) Q3 2025 Results, Indonesia Ruling, and 2026 Outlook
December 20, 2025, 3:08 AM EST. Wilmar International's stock at around S$3.06 on Dec 20, 2025 illustrates a mix of operational gains and legal headwinds. A Sept. 2025 Indonesia Supreme Court ruling requires compensation of about US$708.9 million plus penalties, prompting Wilmar to report a Q3 2025 net loss, though full-year profitability remains intact. In 3Q2025, revenue rose to US$19.07 billion (up ~7%), with a core net profit of US$357.2 million (+71.6%), and net debt easing to US$16.48 billion. The non-recurring charge underscores risk to multiples amid regulated commodity chains. Management flagged improvements across China's oil/flour/rice segments and stronger soybean crushing margins. Investors will weigh these fundamentals against regulatory risks while seeking clearer 2026 guidance.
Wilmar International (SGX:F34) Stock Focus: Q3 2025 Results, Indonesia Penalty, and 2026 Outlook (Dec 20, 2025)
December 20, 2025, 3:07 AM EST. Wilmar International (SGX:F34) closed at S$3.06 on Dec 19, 2025, as markets weigh an operating recovery against regulatory risk from Indonesia. The Indonesia Supreme Court decision demanding about US$708.9 million in state losses, plus fines, looms large, and Wilmar warned of a Q3 2025 net loss due to the payout, even as fundamentals improve. For revenue in Q3 2025, Wilmar reported US$19.07 billion (+7.4% YoY); net loss US$347.7 million; core net profit US$357.2 million (+71.6% YoY); net debt US$16.48 billion. China oil/flour/rice margins and soybean crushing remained supportive. The market faces a potential valuation compression on the back of the one-offs, complicating the 2026 outlook.
Wilmar International (SGX:F34) Stock: Q3 2025 Results, Indonesia Penalty, and 2026 Outlook
December 20, 2025, 3:06 AM EST. Wilmar International (SGX:F34) closed Dec 19 at S$3.06, with a mixed setup as 2025 unfolds. The stock faces two forces: ongoing operational recovery in key agribusinesses and a regulatory/legal overhang from Indonesia and China. A Sept. 2025 Indonesia Supreme Court ruling requires compensation for state losses of about US$709 million (IDR 11.88 trillion) plus fines, pressuring forecasts for Q3 2025 but not necessarily the full year. In 3Q2025, revenue rose to US$19.07 billion (+7.4% YoY) while net loss was US$347.7 million (vs US$254.4 million profit in 3Q2024). Core net profit climbed to US$357.2 million (+71.6% YoY). Net debt dipped to US$16.48 billion. Management cited stronger China oil/flour/rice performance and higher soybean crushing margins, supported by South American supply. Valuation remains sensitive to regulatory risk.
Jardine Matheson Holdings Outlook (SGX: J36): Buyback, CEO Transition & Mandarin Oriental Take-Private
December 20, 2025, 2:39 AM EST. Outlook for Jardine Matheson (SGX: J36, LSE: JAR) into Dec 2025 centers on a US$250 million buyback, a leadership transition with insider buying, and a plan to take Mandarin Oriental private in early 2026. The stock traded near US$67.20 and has rallied about 63% over the past year. Jardine Matheson is a diversified Asia-focused investment holding group, with value driven by assets like Astra, Hongkong Land, DFI Retail and Mandarin Oriental. Key recent data: Q3 trading update kept guidance unchanged and de-levered, with net debt US$25m at end-October. H1 2025 showed underlying profit US$798m, revenue US$17,078m, underlying EPS US$2.73, interim dividend US$0.60, parent free cashflow US$585m, gearing 11%. The themes reflect renewed emphasis on capital returns and long-term value creation.
Genting Singapore Stock News: Moody's Downgrade, RWS 2.0 Spending, and Analyst Targets in Focus
December 20, 2025, 2:38 AM EST. Genting Singapore Limited (G13) trades near S$0.72 with a roughly S$8.65 billion market cap, a P/E around 18.9x and a dividend yield near 5.6%. The stock is back in the crosshairs of capital-markets risk after a string of group-wide ratings moves: on Dec 8, Moody's downgraded Genting Berhad and its subsidiaries, cutting Genting Singapore to Baa1 with a stable outlook. A week later, S&P Global Ratings flipped several Genting group outlooks to negative amid plans for heavy capex. Analysts now weigh whether the focus shifts from a reopening tailwind to a deleveraging/capex-heavy turnaround, including RWS 2.0 spending and a potential New York licence. The key questions: can Resorts World Sentosa regain momentum and how will group leverage affect valuation?
CapitaLand Investment Limited (SGX:9CI) – Latest News, Price Action and Catalysts (as of 20 Dec 2025)
December 20, 2025, 2:37 AM EST. As of 20 December 2025 (a Saturday), there were no SGX prints; CLI closed Friday 19 December at S$2.69, up 1.89% on ~12.17 million shares. Investors digest a week of updates: 14 US-dormant subsidiaries were placed in voluntary liquidation-largely housekeeping with no material impact on NTA or EPS for FY2025; CLI granted 21,728 Restricted Share Plan awards vesting 50% in March 2026 and 2027; and momentum in the China fundraising drive, led by the RMB Master Fund and the closing of CRF I (RMB1 billion size, RMB1.48 billion targeted FUM). The stock traded in a tight range around the mid-S$2.60s; 52-week range roughly S$2.37-S$2.87. The debate remains whether CLI is a rate-sensitive property name or a real-asset manager with a global fee-based model.
India Stock Market Today: Nifty, Sensex Rebound as India VIX Hits Record Low; Rupee Rises
December 20, 2025, 2:36 AM EST. Indian equities closed for the weekend on a rebound, with the Nifty 50 up 0.58% to 25,966.40 and the Sensex up 0.53% at 84,929.36, aided by firmer global cues and a stronger rupee (89.27/$). The India VIX dropped to a record low of 9.52, signaling calm but raising questions about complacency as year-end liquidity dynamics persist. Friday's rally followed improving risk appetite after softer US inflation and expectations of possible rate cuts next year. DII buying outpaced FII inflows on the day, while GIFT Nifty futures suggested a positive Monday open. The rupee's strength provided relief for importers and might ease near-term pressure on rate-sensitive sectors, though forward premia indicate notable hedging costs at year-end. Traders monitor Monday's trades for signs of momentum or risk-off shifts.
Shriram Finance MUFG Deal: ₹39,618 Crore for 20% Stake; Stock Hits Fresh High Ahead of Jan 14, 2026 EGM
December 20, 2025, 2:35 AM EST. Shriram Finance Ltd jumped after MUFG Bank proposed a landmark investment of ₹39,618 crore for a 20% stake on a fully diluted basis, potentially making Shriram an MUFG equity-method affiliate. The deal values the offer at ₹840.93 per share for about 47.11 crore new shares, and would grant MUFG two board seats. Minority protections include pre-emptive rights pro-rata and safeguards that fall away below 10% ownership. A separate $200 million non-compete/non-solicit fee to Shriram Ownership Trust awaits shareholder approvals. The announcement pushed the stock to a fresh 52-week high ahead of an EGM on Jan 14, 2026 to seek approvals. Key near-term catalysts: pricing details, board rights, approvals, and potential subsequent moves.
Singapore Airlines Ltd Stock (SGX: C6L) in Focus: November 2025 Update, Dividend Timeline & Outlook
December 20, 2025, 2:07 AM EST. Singapore Airlines Group (SGX: C6L) saw shares close at S$6.32 (Dec 19), as investors weigh solid travel demand against softer yields and higher non-fuel costs amid Air India exposure. The latest catalysts include the November 2025 operating update showing 2.6% cargo/passenger traffic growth and an 87.3% group PLF, the Dec 23 interim/special dividend payment (ex-date passed) and ongoing Air India risk. With brokers' fair-value targets clustered in the low-to-mid S$6 range, the stock sits near fair value ahead of year-end trading. Investors will track: dividend timing, MTN programme flexibility, and the Air India turnaround's potential cost impact.
Keppel Ltd Stock BN4: Buybacks, Asset Recycling, and Data Centre Deal in Dec 2025
December 20, 2025, 2:06 AM EST. Keppel Ltd (SGX:BN4) ends 2025 on a familiar playbook: regular on-market buybacks, disciplined asset recycling, and a pivot toward an asset manager with real assets exposure. At the Dec 19 close, BN4 = S$10.03, with higher volume as another buyback rolled in (50,000 shares at S$10.01-$10.09), bringing cumulative market acquisitions to about 12.9 million shares. The stock's strength in 2025 is paired with a smoother path to earnings quality from recurring income in infrastructure, connectivity, and funds management. A key late-2025 catalyst is the cash-generative asset recycling by selling the remaining stake in KDC SGP 3 to Keppel DC REIT, underscoring execution of capital allocation. Analysts' price targets for BN4 are closely watched as 20 Dec, with the outlook tethered to buybacks and divestments.
SGX (S68) Stock: Trading Activity, Liquidity Push, and Dividend Outlook Amid Analyst Revisions (Dec 20, 2025)
December 20, 2025, 2:04 AM EST. Singapore Exchange Ltd (SGX: S68) closed near the top of its 52-week range at S$16.87 on Dec 19, 2025, with investors weighing stronger trading activity and a reform-driven push to deepen liquidity and listings in Singapore. Key themes include product expansion (crypto-linked derivatives for institutions) and a defined dividend trajectory for the coming years. Analysts note a mixed near-term view: MarketScreener shows 16 analysts with a Hold consensus and an average target of S$16.98; high S$19.20, low S$14.70. November data highlighted an 18% YoY rise in total securities turnover to S$35.5 billion, supported by index stocks and REITs, reinforcing SGX's operating leverage. Target moves emerged from UOB Kay Hian to S$17.30 and Maybank to S$18.81, amid a structurally higher activity backdrop.
Is Williams-Sonoma Still Attractive After Its Massive Rally? Valuation Insights
December 20, 2025, 1:48 AM EST. Williams-Sonoma (WSM) trades near $190 after a multi-year rally that has driven gains of about 236% over three years and 290% over five. The stock rose 1.8% last week and 9.3% in the past month as investors weigh its omnichannel push, supply-chain gains, and a leaner store footprint with higher-margin brands. On our framework, WSM scores a 3/6 valuation check, meaning it's undervalued on some metrics and fairly valued on others. A two-stage DCF yields an intrinsic value around $202 per share, implying roughly a 5% discount to today's price, i.e., the stock is slightly undervalued at current levels. The longer-term case hinges on margin improvement, disciplined capital allocation, and a shift away from pandemic-era drivers, despite consumer-spending risks.
BlackSky (BKSY) gains 5.5% on rapid Gen-3 satellite commissioning and AI rollout
December 20, 2025, 1:33 AM EST. BlackSky Technology is gaining momentum as its third Gen-3 satellite entered commercial service just three weeks after launch, expanding access to 35-centimeter imagery and AI-enabled analytics via the Spectra platform. The rapid commissioning strengthens the near-term catalyst for a broader Gen-3 ramp and real-time monitoring across defense, aviation, and transportation. But investors must weigh potential upside against capital needs and dilution risk, as the company remains loss-making while funding its constellation and software stack. The recent filing for up to $100 million under an ATM (at-the-market) program highlights the funding challenge even as revenue forecasts project growth toward 2028, with an outlook around $230.4 million in revenue and $16.4 million in earnings. Fair value estimates vary widely, underscoring a binary path depending on execution and conversion to recurring revenue.
Tenet Healthcare (THC): Valuation Revisited After a Strong Run
December 20, 2025, 1:32 AM EST.Tenet Healthcare (THC) has surged this year, prompting a closer look at its long-term upside. At about $196.33, the stock is up roughly 57% year-to-date, with a three-year TSR above 320%, signaling continued momentum as investors bake in growth and contained risk. The stock trades at a modest 12.7x P/E, suggesting the market views Tenet as undervalued versus its performance and peers. On a relative basis, the P/E stands well below peer (23.9x) and sector (23.6x) averages, with a fair value around 24.3x. Our SWS DCF points to a potential price around $370.12, about 47% above today's level. Still, reimbursement pressures and execution risk across hospitals and ambulatory networks could cap further multiple expansion.
UOB Stock Outlook (SGX: U11): Asset Management Options, Hong Kong Property Risk, and 2026 Forecasts
December 20, 2025, 1:31 AM EST. UOB (SGX: U11) ended December on a softer note versus DBS and OCBC as investors weigh three themes: earnings resilience in core banking, rising credit costs tied to property exposure in Greater China, and returns via dividends and a multi-year buyback. A Bloomberg/The Edge Singapore report says UOB is exploring options for its asset management arm (UOBAM), potentially selling or partnering to unlock capital and sharpen strategy. UOBAM held roughly US$37.2 billion in AUM as of Q1. If asset sales or partnerships materialise, capital deployment could shift toward buybacks or higher payouts. Meanwhile, Greater China property risk remains a key overhang, with HK loans heavily skewed to property, which can compress multiples even before actual losses crystallise.
Fortescue Ltd (ASX: FMG) Stock Today: Pullback, Alta Copper Deal, Green Iron Push & 2026 Iron Ore Outlook
December 20, 2025, 1:18 AM EST. Fortescue Ltd (ASX: FMG) is trading amid three forces: a tougher iron ore backdrop, a proposed Alta Copper buyout, and a decarbonisation push into green iron and electrification. FMG closed at A$21.88 on Dec 19, 2025, down 3.23%, with roughly 16.8m shares traded and a 52-week high of A$23.38 hit on Dec 11. Iron ore prices remain resilient as steel output weakens but imports and port stocks stay robust. Looking ahead to 2026, forecasts diverge: Westpac sees a drop to about US$83/t by year-end, while ING and government outlooks remain cautious. The core question for investors: is iron ore support durable enough to underpin margins as Fortescue pursues Alta Copper and new green iron projects?
Takasago Thermal Engineering (TSE:1969) Stock Rises on Strong ROE and Earnings Growth
December 20, 2025, 1:08 AM EST. Shares of Takasago Thermal Engineering (TSE:1969) are up about 6.4% in three months, as investors weigh the company's financials. The stock's trailing ROE stands at about 20%, with net profit growth of roughly 29% over the past five years and a ROE above the industry average of 6.7%. A high ROE paired with reinvestment appears to be supporting future earnings growth, though management's payout ratio and strategic choices may also influence the trajectory. Relative to the sector, Takasago's growth outpaces the broader industry's roughly 11% five-year earnings rise. Investors will want to assess whether the current price fully reflects this earnings growth and potential intrinsic value.
GoldMining (TSX:GOLD) Valuation Check After CA$50 Million ATM Equity Offering
December 20, 2025, 1:07 AM EST. GoldMining (TSX:GOLD) is bolstering its balance sheet with a CA$50 million at-the-market equity program, having already issued CA$17.8 million across multiple price tranches. The stock has rallied, trading near CA$1.82 and delivering a year-to-date return of ~52% and ~57% total return. The key question: does the improved balance sheet justify a valuation premium? GoldMining trades at a Price-to-Book of 2.2x, versus a peer average of ~7.2x and industry 2.8x, suggesting the market assigns a modest premium to its asset base but remains cautious about converting exploration assets into profitable production. Risks include ongoing losses, execution risk on exploration projects, and potential dilution from the ATM program. The article frames whether the stock remains undervalued and what a screen might reveal for related opportunities.
Jack in the Box: Analyst Targets Move as Turnaround Narrative Evolves
December 20, 2025, 1:06 AM EST. Jack in the Box stock is entering a new chapter as Street targets edge up from about $19.89 to $20.56, while the 12.5% discount rate and soft revenue expectations keep the narrative mixed. The pull between optimism around the Del Taco exit and the Jack on Track plan versus caution on soft traffic and a tough quick-service backdrop dominates the debate. On the bull side, Oppenheimer maintains an Outperform rating and trims its target to $24 from $28, projecting 2026 EBITDA of $225M-$240M after the Del Taco sale and seeing clearer guidance that could stabilize earnings power. On the bear side, Piper Sandler, TD Cowen, Goldman Sachs and Stifel have reset targets to roughly $15-$24, citing weak comps, margin pressure, and a challenging near term. Readers can compare views in the Simply Wall St Community.
Bit Digital (BTBT) Valuation Revisited: AI & Ethereum Pivot Sparks Upside
December 20, 2025, 1:05 AM EST. Bit Digital (BTBT) is shifting from pure mining toward an Ethereum staking and AI data-center play, with projects in Canada and Iceland. The stock rose 10.4% to $2.23, after a 90-day return of -28.5% while the 3-year TSR sits near 266%. The thesis: a valuation gap as the market prices in a renewed growth cycle for an ETH-centric pivot and AI infrastructure moat, with a cited fair value around $5.38, suggesting the shares are undervalued. Upside depends on Ethereum resilience and limited dilution; risks include execution delays and crypto volatility. The narrative emphasizes faster scaling, higher margins, and a premium earnings multiple, though the outcome remains tied to the crypto cycle.
BILL Holdings Valuation Check After Rebound: Growth, Margins, and Risks
December 20, 2025, 1:04 AM EST. BILL Holdings has rebounded about 15.4% over the last month while still trading well below peak levels. The setup blends a softer 1-year return with improving fundamentals: analysts expect revenue to grow about 13.2% annually for the next 3 years, and margins could rise from 1.6% to 4.5%. The last close at $55.98 versus a fair value near the low-$60s frames today's price as a potential discount to a recovering SaaS cash machine. Risks include softer SMB spending and stronger competition from larger fintechs. The analysis highlights 4 rewards and 1 warning sign, and invites you to customize a narrative.
GE Vernova Valuation Reassessed: Jefferies Upgrade, Higher Targets, Bigger Buyback and Dividend Hike
December 20, 2025, 1:03 AM EST. GE Vernova (GEV) is under renewed focus after a Jefferies upgrade, an uptick in long-term revenue targets, a doubling of the dividend, and an expanded buyback, signaling management's confidence in AI-driven power demand. The stock has surged about 94% YTD and roughly 92% over a year, but momentum may be moderating even as the long-run uptrend stays intact. The bull case hinges on electrification, grid-solutions backlog, data center electrification, and policy support that could lift wind, gas, and grid revenue. Our valuation sees a fair value around $681.43 (UNDERVALUED) with a roughly 3% cushion, though risks persist from softer European demand, wind segment losses, tariff pressure, and offshore project uncertainty. The stock trades rich versus peers, so a small miss could pressure sentiment.
Sandisk (SNDK) Valuation Reevaluated After 130% 3-Month Rally
December 20, 2025, 1:01 AM EST. Sandisk (SNDK) has surged 132% in 3 months and trades at $237.61, reigniting the question: is this a purchasing opportunity or has the market priced in too much growth? The stock shows strong momentum, but profitability remains under pressure. On a price-to-sales basis, it trades at 4.5x, well above the US tech average of 1.6x and peers, signaling overvaluation relative to current earnings. A contrasting view comes from the DCF model, which fair-valued the stock around $446.29, implying undervaluation on long-term cash flows. Investors must weigh the risk that continued losses or slower revenue growth could temper upside. The gap between the SWS fair ratio and the DCF estimate underscores the split between sentiment and fundamentals.
Caesars Entertainment (CZR) Undervalued After a 22% Rebound?
December 20, 2025, 12:55 AM EST. Caesars Entertainment (CZR) has climbed ~22% in the last month but remains down ~25% YTD, signaling a potential value opportunity for investors. The stock still trades well below prior highs and at a discount to analyst targets and some intrinsic estimates. The bull case centers on digital growth-online casino and sports betting-which could expand the customer base and boost EBITDA margins. However, the bear case notes rising labor and remodeling costs and persistent debt that could squeeze margins and delay cash flow improvements. With a fair value target around $33.37, the narrative hinges on whether rising digital economics can close the gap. Investors should weigh risks and conduct their own number-driven analysis.
Caesars Entertainment (CZR) Appears Undervalued After 22% Rally, According to Narrative Valuation
December 20, 2025, 12:54 AM EST. Caesars Entertainment (CZR) has climbed ~22% in the last month but remains about 25% down year-to-date. At a closing price of $24.38, it trades below a narrative fair value of $33.37, suggesting upside if digital economics-especially online casino and sports betting-continue to lift revenue and margins. The analysis frames a path where digital growth drives higher EBITDA margins and cash flow, supporting an undervalued thesis. Yet, risks include rising labor and remodeling costs and high debt burdens that could compress margins and delay improvement. The narrative invites investors to compare with peers and test a personalized forecast while watching the pace of digitization and leverage unwind to determine if the gap can close.
Caesars Entertainment (CZR): Is the 22% Rebound Hinting at Undervaluation?
December 20, 2025, 12:53 AM EST. Caesars Entertainment has surged about 22% in the last month, yet remains down roughly 25% year-to-date and still trades well below prior highs. The core question is whether the stock is undervalued or simply pricing slower growth. A recent analysis points to a fair value around $33.37 versus a close at $24.38, suggesting upside if the Digital segment – online casino and sports betting – continues expanding profitability and margins. Still, rising labor and remodeling costs and heavy debt burdens could compress margins and delay cash flow gains, tempering the optimistic blueprint. Investors should weigh near-term risks against the potential for digital revenue growth to drive higher EBITDA margins and a re-rated multiple.
Caesars Entertainment (CZR) Undervalued After 22% Rebound? A Deep Dive
December 20, 2025, 12:52 AM EST. Caesars Entertainment (CZR) has rebounded about 22% in a month but remains down ~25% year-to-date, raising questions about valuation. The stock trades at a significant discount to its narrative fair value of $33.37 versus a close around $24.38, suggesting the market may be pricing in slower growth despite online casino and sports betting expansion. The analysis highlights a growing Digital segment delivering higher-margin, recurring revenue, potentially lifting top-line and EBITDA margins. Yet risks persist from rising labor/remodeling costs, a heavy debt burden, and potential margin squeeze that could delay cash flow improvement and cloud the optimistic blueprint. If you prefer, you can craft a personalized narrative-4 key rewards and a screener are offered to tailor ideas around undervalued opportunities like CZR.
Caesars Entertainment (CZR) Undervalued After 22% Monthly Rebound: Digital Growth and Debt in Focus
December 20, 2025, 12:51 AM EST. Caesars Entertainment has climbed about 22% in the last month, yet remains down roughly 25% year to date, signaling a rebound not yet a trend change. With a close at $24.38 and a forward-looking fair value of $33.37, the stock invites value investors to weigh potential upside against rising costs and leverage. Caesars' Digital segment-notably online casino and sports betting-drives higher margin, recurring revenue and could expand top-line growth and EBITDA margins if digital momentum continues. However, labor and remodeling costs and persistent debt burdens threaten margins and cash flow improvements. The question remains: is the stock genuinely undervalued or already pricing in future growth, as highlighted by a narrative-backed benchmark, versus broader risks.
Northern Star Resources (ASX:NST) Stock: Latest News, FY26 Exploration Plan, and 2026 Outlook
December 20, 2025, 12:50 AM EST. NST traded at A$25.82 on 19 December 2025, down 3.37% as bullion-driven moves influence the stock. While gold surged about 64% in 2025 to US$4,381/oz and some institutions see US$5,000/oz in 2026, NST must translate higher bullion into sustainable free cash flow amid costs, royalties, hedging and a heavy capex cycle. The portfolio spans Kalgoorlie and Yandal in WA and Pogo in Alaska, underpinning diversification and multiple levers-mine sequencing, mill expansion, exploration, and a growing power strategy. For FY26 NST outlined a A$225m exploration program, ~73% in-mine growth and ~27% regional, allocated as 42% Kalgoorlie, 25% Yandal, 25% Pogo, 8% Pilbara. A Kalgoorlie renewable energy project is advancing with environmental approvals and a 25-year PPAA.
NST Stock Outlook 2026: Exploration, Costs, and Gold Price Tailwinds for Northern Star Resources (ASX:NST)
December 20, 2025, 12:49 AM EST. Northern Star Resources Ltd (ASX:NST) remains a gold-mining proxy for rising bullion, but 2025 has focused more on execution, costs, capex and translating stronger prices into sustainable free cash flow. The stock closed at A$25.82 on 19 December 2025, trading in a tight range as investors scrutinize margins, royalties and the pace of growth. NST's diversified portfolio spans Kalgoorlie, Yandal, Pogo, and Pilbara, giving it leverage to mine sequencing, mill expansion and a power strategy. Near-term drivers include a heavy investment cycle and evolving hedging. Key catalysts into 2026 include a A$225m FY26 exploration program (≈73% in-mine growth) and the Kalgoorlie renewable energy project with a 25-year PPAA. Gold prices and cash flow remain the core test.
Northern Star Resources NST Stock Update: 2025 Performance, 2026 Forecasts, and Key Catalysts
December 20, 2025, 12:48 AM EST. Northern Star Resources Ltd (ASX:NST) ended 2025 with a mixed view: a gold-leverage stock that now hinges on execution, costs and capex to translate higher bullion into sustainable free cash flow. NST closed at A$25.82 on 19 December 2025, -3.37% for the day as bullion sentiment cooled. The group's Western Australia (Kalgoorlie, Yandal) and Alaska (Pogo) portfolio gives scale and multiple levers-mine sequencing, mill expansion, and a growing power strategy. Bullion strength remains a macro tailwind, with forecasts around US$5,000/oz cited by some institutions for 2026. For FY26, NST guides A$225 million of exploration, split ~73% in-mine and 27% regional, with allocations: Kalgoorlie 42%, Yandal 25%, Pogo 25%, Pilbara 8%. Separately, Kalgoorlie's renewable energy project is advancing through approvals with a 25-year PPAA.
Northern Star Resources NST Stock: 2025 Roundup, FY26 Exploration, and 2026 Outlook
December 20, 2025, 12:47 AM EST. Northern Star Resources Ltd (ASX:NST) traded as a classic gold-leverage play in 2025, but year-end focus shifted toward execution, costs, capex and translating gold strength into free cash flow. NST closed at A$25.82 on 19 December 2025, after a volatile session. The group's portfolio-Kalgoorlie, Yandal, and Pogo-offers scale and diverse levers to lift value, while bullion moves remain a key driver. The question remains: how much of the macro tailwind shows up as sustainable cash flow after royalties and hedging? For FY26, NST guides an exploration spend of A$225m, with ~73% to in-mine growth and ~27% to regional work, across 42% Kalgoorlie, 25% Yandal, 25% Pogo, 8% Pilbara. A Kalgoorlie renewable energy project track includes environmental approvals and a 25-year PPAA.
Northern Star Resources (ASX:NST) Stock: 2026 Outlook, Exploration Spend, and Key Catalysts
December 20, 2025, 12:46 AM EST. Northern Star Resources (ASX:NST) spent 2025 behaving as a classic gold-leverage play: bullion strength lifts the stock, but the real test is execution, costs, capex and translating higher prices into sustainable free cash flow. By 19 December 2025 NST traded around A$25.82, with the share move tethered to bullion sentiment. The macro backdrop remains supportive: futures imply higher bullion paths with central-bank demand and geopolitical risk, even as miners face hedging and royalty headwinds. NST's FY26 plan allocates A$225m to exploration, ~73% for in-mine growth and 27% regional, split across Kalgoorlie (42%), Yandal (25%), Pogo (25%), and Pilbara (8%). Managers emphasise reserve life and production certainty. Also in focus: the Kalgoorlie renewable energy project and a 25-year PPAA, underscoring longer-cycle catalysts into 2026.
Obsidian Energy (TSE:OBE) Stock Up 0.9% as RBC Lifts Target to C$9.50
December 20, 2025, 12:34 AM EST. Obsidian Energy Ltd. (TSE:OBE) shares rose 0.9% Friday, trading as high as C$7.83 and last at C$7.73 on volume of 223,664. Royal Bank of Canada raised its target price from C$9.00 to C$9.50 and kept a sector perform rating. MarketBeat shows an average rating of Hold and a blended target of about C$10.83. The stock has a market cap of C$518.81M, a negative P/E of -2.53, and a beta of 0.13. Liquidity ratios: current 0.45 and quick 0.41; debt-to-equity 20.55. 50-day MA is C$8.34 vs 200-day MA C$8.23. Quarterly earnings were C$0.24 per share; ROE 6.99%, net margin 16.27%, revenue C$114.30M. Insiders bought 37,500 shares in past 90 days; one director purchased 6,900 shares at C$7.85. Obsidian operates in Alberta's Western Canada Sedimentary Basin.
Obsidian Energy (TSE:OBE) Stock Rises 0.9% on RBC Target Increase
December 20, 2025, 12:32 AM EST. Obsidian Energy Ltd. (TSE:OBE) shares rose 0.9% on Friday, trading as high as C$7.83 and last at C$7.73, with volume of 223,664 shares. Royal Bank Of Canada lifted its target from C$9.00 to C$9.50 while keeping a sector perform rating. The stock trades with a market cap around C$519 million, a negative P/E ratio of -2.53, and a beta of 0.13. The company reported Q3 earnings of C$0.24 per share on revenue of C$114.3 million. Insider activity: Director Edward Hume Kernaghan bought 6,900 shares at about C$7.85, increasing ownership to roughly 3.7 million shares. Analysts' consensus is a Hold with a median target near C$10.83. Obsidian Energy operates in Alberta's Western Canada Sedimentary Basin as an intermediate-sized oil and gas producer.
PLS Group Limited (ASX: PLS) – Leadership Refresh, Capital Discipline and Lithium Cycle Outlook
December 20, 2025, 12:31 AM EST. PLS Group Limited (ASX: PLS) – formerly Pilbara Minerals – closes 2025 with a refreshed leadership slate and tighter capital discipline. The company named Alex Willcocks as Chief Financial Officer, effective May 2026, with Flavio Garofalo continuing as interim CFO until then. A board transition brings Robert Nicholson as Non-Executive Director from January 2026 and the retirement of long-serving director Steve Scudamore AM at year-end. The update highlights governance and incentive mechanics, including unquoted securities issued under incentive plans. Operationally, the core Pilgangoora operation in WA remains the anchor, with growth optionality via the Colina Lithium Project in Brazil and downstream exposure through a POSCO JV for battery-grade lithium hydroxide. In a moody lithium cycle, investors will monitor price normalization, demand, especially energy storage, and execution of the global, multi-asset strategy.
Fresenius Medical Care in 2025: Is the Steady Price Hiding a Long-Term Value Opportunity?
December 20, 2025, 12:14 AM EST. Is Fresenius Medical Care quietly becoming a value opportunity as the market debates its long-term outlook? The stock has been rangebound in the near term, up modestly over weeks but down YTD and over the last year, reflecting policy risk and ongoing restructuring. Our model rates the name 5/6 on valuation and flags a wide gap between current price and intrinsic value. A DCF-based framework pegs fair value near €187.79 per share, implying a roughly 78.5% discount to the current price. The story hinges on growing free cash flow, margin discipline from the core dialysis focus, and potential regulatory shifts. Overall, the stock appears undervalued versus its long-run cash generation, offering a potential long-term opportunity for patient investors.
Viatris: Shift Into Complex Therapies Could Reshape the Investment Case for VTRS
December 20, 2025, 12:06 AM EST.Viatris is moving beyond traditional generics into complex injectables, transdermal contraception, and specialty treatments, following four pipeline milestones including FDA approval of a generic Sandostatin LAR Depot. The narrative suggests a gradual shift toward higher-value products but the near-term focus remains on stabilizing margins and improving operational efficiency amid ongoing price erosion in core markets. The key highlight is octreotide acetate for injectable suspension, expanding Viatris' footprint in higher-complexity assets that may be harder to copy. Yet a single product is unlikely to offset overall pricing pressure; investors should weigh the growth potential against a mature, debt-heavy base. Valuation perspectives vary widely (about $10-$50 per share), with a mid-range fair value around $12.44 and an implied upside, if execution improves.
Why Analysts Think Northrop Grumman Could Be Undervalued As Its Defense Story Evolves
December 20, 2025, 12:05 AM EST. Northrop Grumman's fair value barely trims, with a target tick from about $667.21 to $662.68 and a slightly lower discount rate of 7.97%, reflecting less risk. The core thesis stays intact: mid single-digit growth through 2026 and stronger visibility into long-duration programs like Sentinel, B-21, and related space and munitions franchises. Bullish notes from Deutsche Bank ($700) and Bernstein ($674) point to free cash flow beyond 2028, production-readiness, and budget-driven growth in FY 2026. Bearish counterpoints from JPMorgan ($640 neutral) flag near-term risks such as a government shutdown and funding timing. Analysts emphasize Northrop's alignment with long-duration defense priorities, backlog conversion, and resilience of its defense franchises as the stock tracks the evolving narrative.
Is It Too Late to Consider Eldorado Gold After a 330% Three-Year Surge?
December 20, 2025, 12:04 AM EST. Eldorado Gold has surged 330% over three years, with a 116.7% YTD, as gold prices stay elevated and investors rotate into miners. The stock's valuation checks score 5/6, hinting the market may not fully price in its fundamentals. A DCF model points to an intrinsic value around $344 per share, implying the stock could be about 86% undervalued on a cash-flow basis. The analysis notes Eldorado's leverage to higher gold prices and its diversified asset base across jurisdictions, supporting potential upside. But caution remains given near-term uncertainty and the need for sustained cash flow improvement from new projects. Investors should consider whether the current price reflects the long-term earnings power of the portfolio.
Is Canadian Natural Resources Still Undervalued After Its Multi-Year Rally?
December 20, 2025, 12:01 AM EST. Canadian Natural Resources has cooled after a blistering five-year run, but it remains a market favorite for many investors. While shares slipped 3.2% last week and 8.0% last month, the stock is still up double-digits over one year and surged more than 260% over five years, signaling long-term strength amid volatile oil prices and debates over pipelines. Our framework rates CNQ a perfect 6/6 on valuation and flags significant upside. A recent DCF suggests an intrinsic value near CA$167.34 per share, implying about a 73.7% discount to fair value today. With ongoing demand for disciplined capital returns and energy-transition risk pricing, the name warrants fresh consideration, not dismissal.
Mercedes-Benz: Is the Luxury EV Push Keeping the Stock Attractive After a Strong Run?
December 20, 2025, 12:00 AM EST. Mercedes-Benz Group is leaning into premium positioning and a heavy EV push, while keeping capital discipline. The stock has cooled modestly but remains up about 5.1% in the last month, 13.2% YTD, and roughly 70% over five years, signaling a steady re-rating. Our analysis shows a mixed but favorable valuation: a DCF fair value around €73.58 per share suggests the stock is undervalued by ~18.7% versus the current price. The company currently generates about €13.0B in FCF, with forecasts to roughly €6.0B by 2029, underscoring the trade-off between luxury margins and EV investment. Overall, the setup points to a stock that remains attractive to patient investors, though valuation metrics continue to warrant close monitoring of the long-term cash-flow runway.
